Baciject

Baciject may be available in the countries listed below.

Ingredient matches for Baciject

Bacitracin

Bacitracin is reported as an ingredient of Baciject in the following countries:

• Canada

International Drug Name Search

Interome

Interome may be available in the countries listed below.

Ingredient matches for Interome

Cefpirome

Cefpirome sulfate (a derivative of Cefpirome) is reported as an ingredient of Interome in the following countries:

• Indonesia

International Drug Name Search

Rennie Antacidum

Rennie Antacidum may be available in the countries listed below.

Ingredient matches for Rennie Antacidum

Calcium Carbonate

Calcium Carbonate is reported as an ingredient of Rennie Antacidum in the following countries:

• Poland

Magnesium Carbonate

Magnesium Carbonate is reported as an ingredient of Rennie Antacidum in the following countries:

• Poland

International Drug Name Search

Depakote ER Extended-Release Tablets

Pronunciation: dye-VAL-proe-ex
Generic Name: Divalproex
Brand Name: Depakote ER

Life-threatening liver failure has occurred in patients taking Depakote ER Extended-Release Tablets. Children younger than 2 years old are at increased risk of developing life-threatening liver damage, especially those on more than 1 medicine to treat seizures and those with metabolic disorders, severe seizure disorders accompanied by retardation, or organic brain disease. Contact your doctor immediately if you or your child experiences a general feeling of discomfort, sluggishness, weakness, severe drowsiness, swelling of the face, loss of appetite, vomiting, or loss of seizure control. Liver function tests may be performed before and during therapy with Depakote ER Extended-Release Tablets. Be sure to keep all doctor and lab appointments.

Depakote ER Extended-Release Tablets can cause severe birth defects if it is used during pregnancy. Contact your doctor if you become pregnant or think you may be pregnant while taking Depakote ER Extended-Release Tablets. Depakote ER Extended-Release Tablets comes with an additional patient leaflet, "Important Information for Women Who Could Become Pregnant." Read it carefully.

Cases of life-threatening inflammation of the pancreas have occurred with the use of Depakote ER Extended-Release Tablets. Report any stomach pain, nausea, vomiting, or loss of appetite to your doctor at once.

Depakote ER Extended-Release Tablets are used for:

Controlling certain types of seizures in the treatment of epilepsy. It is also used to treat the manic phase of bipolar disorder (manic-depressive illness), and prevent migraine headaches. It may also be used for other conditions as determined by your doctor.

Depakote ER Extended-Release Tablets are an anticonvulsant. It works by reducing or preventing the number of seizures by controlling the abnormal activity of nerve impulses in the brain and central nervous system. Exactly how it works to treat bipolar disorder and migraine headache is not known.

Do NOT use Depakote ER Extended-Release Tablets if:

• you are allergic to any ingredient in Depakote ER Extended-Release Tablets


• you have liver problems or a urea cycle disorder

Contact your doctor or health care provider right away if any of these apply to you.

Video: Treatment for Depression

Treatments for depression are getting better everyday and there are things you can start doing right away.

Before using Depakote ER Extended-Release Tablets:

Some medical conditions may interact with Depakote ER Extended-Release Tablets. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, are breast-feeding, or are of childbearing age


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a history of alcohol abuse, liver problems, metabolic disease, blood disease, HIV infection, cytomegalovirus (CMV) infection, high blood levels of ammonia or glutamine, low body temperature, low levels of albumin, brain problems (eg, organic brain disease), mental retardation, inflammation of the pancreas, kidney problems, or low levels of white blood cells, or if you are scheduled for surgery


• if you have a history of ornithine transcarbamylase deficiency or unexplained coma


• if you have a family history of urea cycle disorders or unexplained infant deaths


• if you have a history of mental or mood problems (eg, depression), or suicidal thoughts or actions


• if you take any other medicine for seizures

Some MEDICINES MAY INTERACT with Depakote ER Extended-Release Tablets. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Benzodiazepines (eg, diazepam), carbamazepine, erythromycin, felbamate, fluoxetine, guanfacine, isoniazid, ketoconazole, risperidone, or salicylates (eg, aspirin) because the risk of serious side effects of Depakote ER Extended-Release Tablets, including changes in vision or other vision problems, clumsiness or unsteadiness, drowsiness, nausea, or vomiting, may be increased


• Clonazepam because the risk of seizures may be increased


• Topiramate because the risk of high ammonium levels, brain problems, or an unusual drop in body temperature may be increased


• Acyclovir, cancer medicines, carbapenem antibiotics (eg, ertapenem, imipenem, meropenem), cholestyramine, hydantoins (eg, phenytoin), mefloquine, nonsteroidal anti-inflammatory drugs (NSAIDs) (eg, ibuprofen), oral contraceptives (eg, birth control pills), or rifampin because they may decrease Depakote ER Extended-Release Tablets's effectiveness


• Anticoagulants (eg, warfarin), barbiturates (eg, phenobarbital), ethosuximide, lamotrigine, methylphenidate, primidone, tolbutamide, tricyclic antidepressants (eg, amitriptyline), or zidovudine because the risk of their side effects may be increased by Depakote ER Extended-Release Tablets

This may not be a complete list of all interactions that may occur. Ask your health care provider if Depakote ER Extended-Release Tablets may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Depakote ER Extended-Release Tablets:

Use Depakote ER Extended-Release Tablets as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• An extra patient leaflet is available with Depakote ER Extended-Release Tablets. Talk to your pharmacist if you have questions about this information.


• Take Depakote ER Extended-Release Tablets by mouth with or without food. If stomach upset occurs, take with food to reduce stomach irritation.


• Swallow Depakote ER Extended-Release Tablets whole. Do not break, crush, or chew before swallowing.


• Taking Depakote ER Extended-Release Tablets at the same time each day will help you remember to take it.


• Do not stop taking Depakote ER Extended-Release Tablets suddenly, especially if you are taking Depakote ER Extended-Release Tablets to prevent seizures. Suddenly stopping Depakote ER Extended-Release Tablets may cause severe seizures to occur. If you need to stop Depakote ER Extended-Release Tablets, your doctor will gradually lower your dose.


• Continue to take Depakote ER Extended-Release Tablets even if you feel well. Do not miss any doses. Depakote ER Extended-Release Tablets works best when there is a constant level of it in your body.


• If you miss a dose of Depakote ER Extended-Release Tablets, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Depakote ER Extended-Release Tablets.

Important safety information:

• Depakote ER Extended-Release Tablets may cause drowsiness, dizziness, or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use Depakote ER Extended-Release Tablets with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Do not drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Depakote ER Extended-Release Tablets; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.


• Tell your doctor or dentist that you take Depakote ER Extended-Release Tablets before you receive any medical or dental care, emergency care, or surgery.


• Inflammation of the pancreas is a potentially life-threatening illness associated with Depakote ER Extended-Release Tablets. Symptoms include stomach pain, vomiting, or loss of appetite. Contact your doctor at once if any of these symptoms occur.


• Patients who take Depakote ER Extended-Release Tablets may be at increased risk for suicidal thoughts or actions. The risk may be greater in patients who have had suicidal thoughts or actions in the past. Patients who have bipolar (manic-depressive) illness may also have an increased risk for suicidal thoughts or actions. Watch patients who take Depakote ER Extended-Release Tablets closely. Contact the doctor at once if new, worsened, or sudden symptoms, such as depressed mood; anxious, restless, irritable behavior; panic attacks; or any unusual change in mood or behavior occur. Contact the doctor right away if any signs of suicidal thoughts or actions occur.


• Depakote ER Extended-Release Tablets may reduce the number of clot-forming cells (platelets) in your blood. Avoid activities that may cause bruising or injury. Tell your doctor if you have unusual bruising or bleeding. Tell your doctor if you have dark, tarry, or bloody stools.


• Diabetes patients - Depakote ER Extended-Release Tablets may cause the results of some tests for urine ketones to be wrong. Ask your doctor before you change your diet or the dose of your diabetes medicine.


• Depakote ER Extended-Release Tablets may increase the ammonia levels in your blood. Contact your doctor right away if you experience unexplained sluggishness and vomiting or mental changes.


• Depakote ER Extended-Release Tablets may cause an unusual drop in body temperature (hypothermia). Symptoms may include confusion, lack of energy, loss of coordination, shivering, slow heartbeat, slow or shallow breathing, slurred speech, or unusual drowsiness. Contact your doctor right away if you have any of these symptoms.


• Depakote ER Extended-Release Tablets may interfere with certain lab tests, including thyroid function. Be sure your doctor and lab personnel know you are taking Depakote ER Extended-Release Tablets


• Lab tests, including complete blood cell counts, blood ammonia levels, and liver function, may be performed while you use Depakote ER Extended-Release Tablets. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Use Depakote ER Extended-Release Tablets with caution in the ELDERLY; they may be more sensitive to its effects, especially drowsiness.


• Depakote ER Extended-Release Tablets should be used with extreme caution in CHILDREN younger than 10 years old; safety and effectiveness in these children have not been confirmed. CHILDREN younger than 2 years old may be at increased risk of serious liver problems.


• PREGNANCY and BREAST-FEEDING: Depakote ER Extended-Release Tablets has been shown to cause harm to the fetus. Use an effective form of birth control while you take Depakote ER Extended-Release Tablets. If you think you may be pregnant or if you wish to become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Depakote ER Extended-Release Tablets while you are pregnant. Depakote ER Extended-Release Tablets are found in breast milk. Do not breast-feed while you are taking Depakote ER Extended-Release Tablets.

Possible side effects of Depakote ER Extended-Release Tablets:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Change in appetite; constipation; diarrhea; dizziness; drowsiness; hair loss; headache; indigestion; nausea; stomach cramps or pain; trouble sleeping; vomiting; weakness; weight changes.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); abnormal thinking; change in menstrual period; changes in behavior; chest pain; confusion; dark, tarry, or bloody stools; dark urine; difficulty speaking; difficulty urinating or other urination problems; extreme tiredness; fast or irregular heartbeat; hallucinations; hearing loss; involuntary movements of the arms and legs; involuntary movements or chewing movements of the face, jaw, mouth, or tongue; joint pain; lack of energy; loss of appetite; loss of coordination; loss of seizure control; memory loss; new or worsening mental or mood changes (eg, aggressiveness, agitation, anxiety, depression, exaggerated feeling of well-being, hostility, impulsiveness, inability to sit still, irritability, panic attacks, restlessness); nosebleed; pounding in the chest; red, swollen, blistered, or peeling skin; severe or persistent nausea, vomiting, or stomach pain; shortness of breath; suicidal thoughts or actions; swelling of the arms or legs; symptoms of infection (eg, fever, chills, sore throat); tremor; unusual bleeding or bruising; unusual weakness; vision changes or blurred vision; yellowing of the skin or eyes.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Depakote ER side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include deep sleep; drowsiness; irregular heartbeat; loss of consciousness.

Proper storage of Depakote ER Extended-Release Tablets:

Store Depakote ER Extended-Release Tablets at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Depakote ER Extended-Release Tablets out of the reach of children and away from pets.

General information:

• If you have any questions about Depakote ER Extended-Release Tablets, please talk with your doctor, pharmacist, or other health care provider.


• Depakote ER Extended-Release Tablets are to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Depakote ER Extended-Release Tablets. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Depakote ER resources

• Depakote ER Side Effects (in more detail)
• Depakote ER Dosage
• Depakote ER Use in Pregnancy & Breastfeeding
• Drug Images
• Depakote ER Drug Interactions
• Depakote ER Support Group
• 32 Reviews for Depakote ER - Add your own review/rating

Compare Depakote ER with other medications

• Bipolar Disorder
• Epilepsy
• Hyperekplexia
• Mania
• Migraine Prevention

Floran

Floran may be available in the countries listed below.

Ingredient matches for Floran

Isoflurane

Isoflurane is reported as an ingredient of Floran in the following countries:

• Bahrain


• Egypt


• Iraq


• Jordan


• Kuwait


• Lebanon


• Libya


• Oman


• Qatar


• Saudi Arabia


• Sudan


• Syria


• Tunisia


• United Arab Emirates


• Yemen

International Drug Name Search

Metronidazol SAD

Metronidazol SAD may be available in the countries listed below.

Ingredient matches for Metronidazol SAD

Metronidazole

Metronidazole is reported as an ingredient of Metronidazol SAD in the following countries:

• Denmark

International Drug Name Search

Maxiclear Relief

Maxiclear Relief may be available in the countries listed below.

Ingredient matches for Maxiclear Relief

Phenylephrine

Phenylephrine hydrochloride (a derivative of Phenylephrine) is reported as an ingredient of Maxiclear Relief in the following countries:

• New Zealand

International Drug Name Search

Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension

Pronunciation: DEX-brome-fen-IR-a-meen/FEN-il-EF-rin/pir-IL-a-meen
Generic Name: Dexbrompheniramine/Phenylephrine/Pyrilamine
Brand Name: Poly Tan D

Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension is used for:

Relieving symptoms of sinus congestion, pressure, runny nose, and sneezing due to colds, upper respiratory infections, and allergies. It may also be used for other conditions as determined by your doctor.

Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension is an antihistamine and decongestant combination. The antihistamines work by blocking the action of histamine, which helps reduce symptoms such as watery eyes and sneezing. The decongestant promotes sinus and nasal drainage, which relieves congestion and pressure.

Do NOT use Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension if:

• you are allergic to any ingredient in Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension


• you have severe high blood pressure, severe heart blood vessel disease, rapid heartbeat, or severe heart problems


• you are taking sodium oxybate (GHB) or you have taken furazolidone or a monoamine oxidase inhibitor (MAOI) (eg, phenelzine) within the last 14 days

Contact your doctor or health care provider right away if any of these apply to you.

Before using Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension:

Some medical conditions may interact with Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a fast, slow, or irregular heartbeat


• if you have a history of asthma; lung problems (eg, emphysema); sleep apnea; adrenal gland problems (eg, adrenal gland tumor); heart problems; high blood pressure; diabetes; blood vessel problems; stroke; glaucoma or increased pressure in the eye; a blockage of your bladder, stomach, or intestines; ulcers; trouble sleeping; trouble urinating; an enlarged prostate or other prostate problems; seizures; kidney problems; thyroid problems; or phenylketonuria

Some MEDICINES MAY INTERACT with Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Digoxin or droxidopa because the risk of irregular heartbeat or heart attack may be increased


• Beta-blockers (eg, propranolol), catechol-O-methyltransferase (COMT) inhibitors (eg, tolcapone), furazolidone, indomethacin, MAOIs (eg, phenelzine ), sodium oxybate (GHB), or tricyclic antidepressants (eg, amitriptyline) because they may increase the risk of Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension's side effects


• Bromocriptine or hydantoins (eg, phenytoin) because the risk of their side effects may be increased by Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension


• Guanadrel, guanethidine, mecamylamine, methyldopa, or reserpine because their effectiveness may be decreased by Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension

This may not be a complete list of all interactions that may occur. Ask your health care provider if Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension:

Use Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Take Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension by mouth with or without food.


• Shake well before each use.


• Use a measuring device marked for medicine dosing. Ask your pharmacist for help if you are unsure of how to measure your dose.


• If you miss a dose of Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension.

Important safety information:

• Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension may cause drowsiness, dizziness, or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Check with your doctor before you drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.


• Do not take diet or appetite control medicines while you are taking Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension without checking with your doctor.


• Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension has dexbrompheniramine, pyrilamine, and phenylephrine in it. Before you start any new medicine, check the label to see if it has an antihistamine or a decongestant in it too. If it does or if you are not sure, check with your doctor or pharmacist.


• Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor.


• If your symptoms do not get better within 5 to 7 days or if they get worse, check with your doctor.


• Some of these products contain phenylalanine. If you must have a diet that is low in phenylalanine, ask your pharmacist if it is in your product.


• Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension may cause you to become sunburned more easily. Avoid the sun, sunlamps, or tanning booths until you know how you react to Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension. Use a sunscreen or wear protective clothing if you must be outside for more than a short time.


• Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension may interfere with skin allergy tests. If you are scheduled for a skin test, talk to your doctor. You may need to stop taking Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension for a few days before the tests.


• Tell your doctor or dentist that you take Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension before you receive any medical or dental care, emergency care, or surgery.


• Use Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension with caution in the ELDERLY; they may be more sensitive to its effects, especially confusion, dizziness, drowsiness, dry mouth, excitability, low blood pressure, and trouble urinating.


• Caution is advised when using Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension in CHILDREN; they may be more sensitive to its effects, especially excitability.


• Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension should not be used in CHILDREN younger than 2 years old; safety and effectiveness in these children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension while you are pregnant. Do not take Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension in the third trimester of pregnancy. Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension is found in breast milk. Do not breast-feed while taking Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension.

Possible side effects of Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension:

All medicines may cause side effects, but many people have no, or minor side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Constipation; diarrhea; dizziness; drowsiness; dry mouth; excitability; headache; loss of appetite; nausea; nervousness or anxiety; trouble sleeping; upset stomach; vomiting; weakness.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); blurred vision or other vision changes; difficulty urinating or inability to urinate; fast or irregular heartbeat; hallucinations; mood or mental changes; persistent trouble sleeping; restlessness; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; tremor.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Dexbrompheniramine/Phenylephrine/Pyrilamine side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include blurred vision; confusion; hallucinations; ringing in the ears; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; unusually fast, slow, or irregular breathing; unusually fast, slow, or irregular heartbeat.

Proper storage of Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension:

Store Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension out of the reach of children and away from pets.

General information:

• If you have any questions about Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension, please talk with your doctor, pharmacist, or other health care provider.


• Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Dexbrompheniramine/Phenylephrine/Pyrilamine Suspension. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Dexbrompheniramine/Phenylephrine/Pyrilamine resources

• Dexbrompheniramine/Phenylephrine/Pyrilamine Side Effects (in more detail)
• Dexbrompheniramine/Phenylephrine/Pyrilamine Use in Pregnancy & Breastfeeding
• Dexbrompheniramine/Phenylephrine/Pyrilamine Drug Interactions
• Dexbrompheniramine/Phenylephrine/Pyrilamine Support Group
• 0 Reviews for Dexbrompheniramine/Phenylephrine/Pyrilamine - Add your own review/rating

Compare Dexbrompheniramine/Phenylephrine/Pyrilamine with other medications

• Nasal Congestion